Sequelae costs averted by treatment of people with chlamydia and gonorrhea

Base case  54%, Base case + 60%

Sequelae costs averted by treatment of people with syphilis

Base case  28%, Base case + 28%

Congenital syphilis treatment costs averted

Base case  36%, Base case + 39%

Treatment and sequelae costs averted by reducing STIs in the population

Base case  53%, Base case + 58%

HIV costs averted through treatment of STIs

Base case  67%, Base case + 80%

HIV costs averted by HIV counseling and testing

Base case  54%, Base case + 60%

Indirect chlamydia and gonorrhea costs averted

Base case  35%, Base case + 38%

Indirect syphilis costs averted

Base case  35%, Base case + 38%

Indirect congenital syphilis costs averted

Base case  36%, Base case + 39%

Indirect HIV costs averted through treatment of STIs

Base case  67%, Base case + 80%

Indirect HIV costs averted by HIV counseling and testing

Base case  54%, Base case + 60%
